InVivoMAb Anti-Campylobacter jejuni subsp. wlaB/pglK Nanobody (Iv0202) (JN929010)

Name: InVivoMAb Anti-Campylobacter jejuni subsp. wlaB/pglK Nanobody (Iv0202)
Brand: abinScience
SKU: JN929010
Price: 370 USD
Availability: InStock

Datasheet Compartir producto Copiar información

Precio(USD):

Especificación:

100ug
1mg

Número:

Contáctenos

Vista general
Imágenes
Referencias
Datasheet
SDS

Vista general

Número de catálogo	JN929010
Descripción	InVivoMAb Anti-Campylobacter jejuni subsp. wlaB/pglK Nanobody (Iv0202) [Iv0202] (JN929010) is a alpaca monoclonal antibody detecting Protein glycosylation K in ELISA, Neutralization.
Reactividad de especies	Campylobacter jejuni
Aplicaciones	ELISA, Neutralization
Especie huésped	Alpaca
Clonalidad	Monoclonal
Isotipo	VHH-8His-Cys-tag
ID de clon	Iv0202
Objetivo	Protein glycosylation K, 7.5.2.5, pglK, wlaB, Cj1130c
Nivel de endotoxinas	<0.01 EU/ug
Pureza	>95% as determined by SDS-PAGE.
Productos asociados	pH 7.4 Dilution Buffer
Purificación	Purified by Nickel column.
Número de acceso	Q0P9C4
Forma	Liquid
Buffer de almacenamiento	0.01M PBS pH 7.4 Consulte la información específica del buffer en la copia impresa del datasheet o en el COA específico del lote.
Estabilidad y almacenamiento	Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Fondo	Protein glycosylation K (wlaB/pglK) is a ~64 kDa protein. Mediates the ATP-dependent translocation of the undecaprenylpyrophosphate-linked heptasaccharide intermediate across the cell membrane; this is an essential step during the N-linked protein glycosylation pathway. Transport across the membrane is effected via ATP-driven conformation changes. Most likely, only the polar and charged part of the glycolipid enter the substrate-binding cavity, and the lipid tail remains exposed to the membrane lipids during the transmembrane flipping process.
Nota	For research use only. Not suitable for clinical or therapeutic use.

Imágenes

SDS-PAGE

SDS-PAGE for InVivoMAb Anti-Campylobacter jejuni subsp. wlaB/pglK Nanobody (Iv0202).

Referencias

Datasheet

InVivoMAb Anti-Campylobacter jejuni subsp. wlaB/pglK Nanobody (Iv0202).pdf

Download SDS PDF

Formula

Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)

Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.

Mass

Concentration

Volume

Molecular Weight *

g/mol

Formula

C₁ × V₁ = C₂ × V₂

Enter any 3 of the 4 values to solve for the unknown.

Stock Solution

C₁ (Stock Conc.)

V₁ (Stock Vol.)

Working Solution

C₂ (Working Conc.)

V₂ (Working Vol.)

Proteínas Recombinantes

Anticuerpos

Kits de Ensayo